1. Bleehen NM, Stenning SP. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br J Cancer. 1991; 64:769–774. PMID:
1654987.
Article
2. Chang SM, Seiferheld W, Curran W, Share R, Atkins J, Choucair A, et al. Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813) : implications for studies testing initial treatment of brain tumors. Int J Radiat Oncol Biol Phys. 2004; 59:1122–1126. PMID:
15234047.
Article
3. Desjardins A, Reardon DA, Vredenburgh JJ. Current available therapies and future directions in the treatment of malignant gliomas. Biologics. 2009; 3:15–25. PMID:
19707392.
4. Eyre HJ, Eltringham JR, Gehan EA, Vogel FS, Al-Sarraf M, Talley RW, et al. Randomized comparisons of radiotherapy and carmustine versus procarbazine versus dacarbazine for the treatment of malignant gliomas following surgery : a Southwest Oncology Group Study. Cancer Treat Rep. 1986; 70:1085–1090. PMID:
3017551.
5. Green SB, Byar DP, Walker MD, Pistenmaa DA, Alexander E Jr, Batzdorf U, et al. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep. 1983; 67:121–132. PMID:
6337710.
6. Hildebrand J, Sahmoud T, Mignolet F, Brucher JM, Afra D. EORTC Brain Tumor Group. Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas. Neurology. 1994; 44:1479–1483. PMID:
8058153.
Article
7. Kim IH, Park CK, Heo DS, Kim CY, Rhee CH, Nam DH, et al. Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas : a prospective randomized controlled multicenter phase III trial. J Neurooncol. 2011; 103:595–602. PMID:
21052775.
Article
8. Levin VA, Silver P, Hannigan J, Wara WM, Gutin PH, Davis RL, et al. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas : NCOG 6G61 final report. Int J Radiat Oncol Biol Phys. 1990; 18:321–324. PMID:
2154418.
Article
9. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114:97–109. PMID:
17618441.
Article
10. Medical Research Council Brain Tumor Working Party. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma : a Medical Research Council trial. J Clin Oncol. 2001; 19:509–518. PMID:
11208845.
11. Prados MD, Scott C, Curran WJ Jr, Nelson DF, Leibel S, Kramer S. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma : a retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy. J Clin Oncol. 1999; 17:3389–3395. PMID:
10550132.
Article
12. Stupp R, Reni M, Gatta G, Mazza E, Vecht C. Anaplastic astrocytoma in adults. Crit Rev Oncol Hematol. 2007; 63:72–80. PMID:
17478095.
Article
13. Walker MD, Alexander E Jr, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg. 1978; 49:333–343. PMID:
355604.
Article
14. Walker MD, Green SB, Byar DP, Alexander E Jr, Batzdorf U, Brooks WH, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med. 1980; 303:1323–1329. PMID:
7001230.
Article
15. Yung WK, Prados MD, Yaya-Tur R, Rosenfeld SS, Brada M, Friedman HS, et al. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol. 1999; 17:2762–2771. PMID:
10561351.